 |
 |
 |
|
||
To visit the main website, click here
or on the Riner Group Logo above
|
A decade ago, pharmaceutical companies announced a revolutionary way of finding new drugs. Instead of relying on scientists’ hunches about what chemicals to experiment with, they bought into machines to create thousands of chemical combinations. The new technology was supposed to bring a flood of new medicines to patients and profits to investors.
Today, some leading chemists are calling the effort an expensive potential fiasco. Useful results were few and far between. Chemicals that seemed promising often turned out to have significant flaws. The dearth of new products has forced companies to seek growth by heavily promoting their existing product lines through minor modifications. 
|
|
|
Insurers and the government contract with hospitals for discounts on charges. Patients without insurance generally are not able to win such large discounts. Below are examples of the average amount paid per admission, for two common health conditions, based on data collected by the state of California. Uninsured pay more.
|
|
|
Physicians are growing increasingly disillusioned with their profession, according to a recent study by recruiter Merritt Hawkins & Associates. The survey drew responses from 436 physicians ages 50 – 65. About 50% of the physicians said they would not choose medicine as a career if they were starting out today.
|
|
|
Healthcare services and social assistance accounted for $1.2 trillion of the American economy in 2002, up from $1.1 trillion in 2001, the US Census Bureau said in a new report. Total revenue for all US hospitals, including general, psychiatric, specialty and substance abuse treatment rose 9.7% to $507.2 billion in 2002 from $462.2 billion in 2001. Physician offices collected $249.6 billion, outpatient centers $72.2 billion, and home health providers $34.4 billion in 2002.
|
|
| We have the pleasure of working with many hospitals in development of their new programs and heart centers. The booming hospital construction market is likely to continue for some time. A recent survey of 200 senior executives undertaken by The Turner Construction Company noted that 70% of hospital executives stated that their institutions were very likely or extremely likely to undertake a major expansion within the next three years. The survey also found that the construction market for specialty hospitals would probably continue to grow, despite healthcare executives’ concerns about competition. 
|
|
|
Total EMR sales to physician practices should go up from $816 million in 2003 to about $1.4 billion in 2008.
Forrester Research estimates that sales of electronic medical records will shift gradually with small physician practices dominating the market. Pressure from payers and a growing interest in work efficiency has smaller practices looking more seriously at undertaking an electronic medical record format. 
|
|
|
Venture capital investors last year provided $3.4 billion for biotech start-ups.
The biotech industry has fewer than 1,500 companies and fewer than 200,000 workers. Only about 100 biotech drugs reached the market in 30 years. Genetech and Amgen are among the few profitable biotech companies whose names are well known. Many biotech drugs fail in the testing stage, leaving the industry sorely needing some successes. Global losses in 2002, the most recent year available, more than doubled to $12.5 billion from $5.8 billion in 2001, according to a recent Ernst and Young survey. Pharmaceutical companies are relying more on biotech start-ups and their investors for new drugs to fight cancer and other illnesses. That is drawing more venture capital investors to the biotech arena. This will be an interesting story to watch unfold. 
|
To find out more about The Riner Group,
please visit our website
or contact
us directly via confidential voicemail or fax.
|
#TrackReads#
|
5811 Pelican Bay Blvd, Suite. 210 |
Naples, FL 34108 |
314.727.7098 |
1.800.965.8485
|
Copyright - The Riner Group, 2010 |
|||